Observational Study of Nivolumab in Patients in Germany With Squamous Cell Carcinoma of the Head and Neck Progressing on or After Platinum-Based Therapy

Condition:   Head and Neck Cancer
Intervention:   Other: Non-Interventional
Sponsor:   Bristol-Myers Squibb
Not yet recruiting - verified April 2017

http://ift.tt/2ouhk26